FFA
UTHR icon

Florida Financial Advisors’s United Therapeutics UTHR Stock Holding History

Florida Financial Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Buy
606
+28
+5% +$15.8K 0.06% 259
2026
Q1 		$343K Buy
578
+28
+5% +$13.9K 0.08% 222
2025
Q4 		$268K Buy
550
+28
+5% +$13K 0.07% 231
2025
Q3 		$219K Buy
+522
New +$176K 0.07% 247
2025
Q2 		– Sell
-1,260
Closed -$388K – 281
2025
Q1 		$388K Buy
1,260
+438
+53% +$150K 0.15% 138
2024
Q4 		$290K Buy
822
+48
+6% +$17.6K 0.13% 147
2024
Q3 		$277K Buy
774
+146
+23% +$49.3K 0.14% 139
2024
Q2 		$200K Buy
+628
New +$166K 0.12% 145

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Florida Financial Advisors's UTHR Position: Q2 2026 in Review

Florida Financial Advisors increased its United Therapeutics (UTHR) stake by 4.8% in Q2 2026, buying an estimated $15.8K and bringing the position to 606 shares worth $328K. The position accounts for 0.06% of the portfolio, ranked #259.

Florida Financial Advisors first reported a position in UTHR in Q2 2024 and has held it in 8 quarters since. The position peaked at $388K in Q1 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Florida Financial Advisors held 606 shares of United Therapeutics worth $328K as of Q2 2026.
  • Florida Financial Advisors bought 28 United Therapeutics shares in Q2 2026, an estimated $15.8K.
  • United Therapeutics made up 0.06% of Florida Financial Advisors's portfolio in Q2 2026, its #259 holding.
  • Florida Financial Advisors first reported a position in United Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Florida Financial Advisors's United Therapeutics position peaked at $388K in Q1 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Florida Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.